PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.\', \'MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, UK.\', \'Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.\', \'Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, UK.\', \'University of Georgia, Athens, GA, USA.\', \'Fogarty International Center, National Institutes of Health, Bethesda, MD, USA. Electronic address: david.spiro@nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00425-410.1016/j.vaccine.2021.03.096
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 33895016
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • RSV genomic diversity and the development of a globally effective RSV intervention.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33895016>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33895016>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all